User profiles for D. Taboada
 | Dolores TaboadaPulmonary Vascular Diseases Consultant Verified email at nhs.net Cited by 1592 |
Pulmonary hypertension and its management in patients undergoing non‐cardiac surgery
SA Pilkington, D Taboada, G Martinez - Anaesthesia, 2015 - Wiley Online Library
Pulmonary hypertension is a complex disorder of the pulmonary vasculature that leads to
increased peri‐operative morbidity and mortality. Non‐cardiac surgery constitutes a significant …
increased peri‐operative morbidity and mortality. Non‐cardiac surgery constitutes a significant …
[HTML][HTML] Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert …
…, G Coghlan, BE Schreiber, J Lordan, D Taboada… - British journal of …, 2021 - Elsevier
Background The risk of complications, including death, is substantially increased in patients
with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, …
with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, …
Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort
Background— Chronic thromboembolic pulmonary hypertension results from incomplete
resolution of pulmonary emboli. Pulmonary endarterectomy (PEA) is potentially curative, but …
resolution of pulmonary emboli. Pulmonary endarterectomy (PEA) is potentially curative, but …
Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease
Chronic thromboembolic disease is characterised by persistent pulmonary thromboembolic
occlusions without pulmonary hypertension. Early surgical treatment with pulmonary …
occlusions without pulmonary hypertension. Early surgical treatment with pulmonary …
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon
complication of acute pulmonary emboli necessitating lifelong anticoagulation. Despite this, …
complication of acute pulmonary emboli necessitating lifelong anticoagulation. Despite this, …
Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter
…, AN Priest, D Gopalan, D Taboada… - Journal of applied …, 2014 - journals.physiology.org
Pressure-volume loops describe dynamic ventricular performance, relevant to patients with
and at risk of pulmonary hypertension. We used conductance catheter-derived pressure-…
and at risk of pulmonary hypertension. We used conductance catheter-derived pressure-…
[HTML][HTML] Extraparenchymal neurocysticercosis: demographic, clinicoradiological, and inflammatory features
…, F García Hernández, D Taboada… - PLoS neglected …, 2017 - journals.plos.org
Background Extraparenchymal neurocysticercosis (ExPNCC), an infection caused by
Taenia solium cysticerci that mainly occurs in the ventricular compartment (Ve) or the basal …
Taenia solium cysticerci that mainly occurs in the ventricular compartment (Ve) or the basal …
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
Objective Inoperable chronic thromboembolic pulmonary hypertension (CTEPH) managed
medically has a poor prognosis. Balloon pulmonary angioplasty (BPA) offers a new treatment …
medically has a poor prognosis. Balloon pulmonary angioplasty (BPA) offers a new treatment …
[HTML][HTML] The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension
… Therefore, we used fibrinogen degradation products measured by D-dimer as a potential
surrogate marker of plasmin and thrombin activity. D-dimer was increased in CTEPH (1.24 (1.25…
surrogate marker of plasmin and thrombin activity. D-dimer was increased in CTEPH (1.24 (1.25…
[HTML][HTML] EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial …
… In our study, which included much larger numbers of patients with (I/D/H)PAH and CTD-PAH,
emPHasis-10 was an independent prognostic marker in (I/D/H)PAH and CTD-PAH, even …
emPHasis-10 was an independent prognostic marker in (I/D/H)PAH and CTD-PAH, even …